Approximately 371 million people—that’s one in 19 people worldwide—are currently affected by diabetes,1 and unless rapid action is taken, one person in 10 will have diabetes by 2030.2 The disease creates quality of life and health challenges for nearly everyone it affects. For example, people with diabetes are two-to-four times more likely to suffer a heart attack or stroke than people without diabetes.3 People with diabetes are also at risk for many other health complications, such as kidney failure, blindness, lower-limb amputations and death.4 These factors make proper management vitally important to people with diabetes.
November 14 is World Diabetes Day, an annual initiative launched by the International Diabetes Federation (IDF) and its member associations to raise global awareness and draw attention to issues of paramount importance to the diabetes world.
TYPE 1 AND TYPE 2 DIABETES
People with diabetes are diagnosed with either type 1 or type 2, which is distinguished by how the person’s body interacts with insulin. For people with type 1 diabetes, the pancreas does not produce insulin because the body’s immune system has attacked and destroyed the cells that produce it. Type 1 diabetes is usually diagnosed in younger people. This group of patients must manage their disease very carefully by taking insulin, monitoring blood glucose levels (often multiple times each day), making wise food choices and being physically active.5, 6
Type 2 diabetes is by far the most common form of diabetes. In type 2 diabetes, the body either does not produce enough insulin or the cells do not respond to it normally.7 Being overweight and lacking physical activity increase a person’s chances of developing type 2 diabetes.8
ABBOTT'S COMMITMENT TO DIABETES MANAGEMENT
Abbott markets a number of products to aid in the diagnosis, monitoring and treatment of diabetes:
The FreeStyle brand of products is intended for testing outside the body (in vitro diagnostic use) as an aid to monitor the effectiveness of diabetes control. The products should not be used for the diagnosis of or screening for diabetes or for neonatal use.
Use under medical supervision as part of a diabetes management plan.
Les liens qui vous emmènent hors des sites Web mondiaux d’Abbott ne sont pas sous le contrôle d’Abbott et Abbott n’est pas responsable du contenu de ces sites ou de tous autres liens d’un tel site. Abbott vous fournit ces liens uniquement à titre de commodité et l’inclusion de tout lien ne signifie pas l’approbation par Abbott du site lié.
Le site Web que vous avez demandé peut aussi ne pas être optimisé pour votre taille d’écran en particulier.